The Immune Synapse as a Novel Target for Therapy

Editors:

ISBN: 978-3-7643-8295-7 (Print) 978-3-7643-8296-4 (Online)

Table of contents (12 chapters)

  1. Front Matter

    Pages i-xii

  2. No Access

    Book Chapter

    Pages 1-13

    The immune synapse and T cell activation: regulation by chemokines

  3. No Access

    Book Chapter

    Pages 15-34

    The induction of regulatory T cells by targeting the immune synapse

  4. No Access

    Book Chapter

    Pages 35-47

    Infiltrating the immunological synapse: prospects for the use of altered peptide ligands for the treatment of immune pathology

  5. No Access

    Book Chapter

    Pages 49-56

    Targeting CD4 for the induction of dominant tolerance

  6. No Access

    Book Chapter

    Pages 57-70

    Anti-CD3: from T cell depletion to tolerance induction

  7. No Access

    Book Chapter

    Pages 71-86

    Immune modulation by CD40L blockade

  8. No Access

    Book Chapter

    Pages 87-106

    CTLA-4-immunoglobulin and indoleamine 2,3-dioxygenase in dominant tolerance

  9. No Access

    Book Chapter

    Pages 107-128

    Adhesion molecules as therapeutic targets

  10. No Access

    Book Chapter

    Pages 129-146

    E3 ubiquitin ligases and immune tolerance: Targeting the immune synapse from within?

  11. No Access

    Book Chapter

    Pages 147-154

    FOXP3 biochemistry will lead to novel drug approaches for vaccines and diseases that lack suppressor T cells

  12. No Access

    Book Chapter

    Pages 155-168

    Transforming growth factor-β: From its effect in T cell activation to a role in dominant tolerance

  13. No Access

    Book Chapter

    Pages 169-185

    From mice to men: the challenges of developing tolerance-inducing biological drugs for the clinic

  14. Back Matter

    Pages 187-192